Last update :
17/09/2021
Antiviral   Aciclovir sodium  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Abaciclovir Brazil
Abbovir Poland
Acevir Peru
Aciclobene Austria
Acicloget Peru
Aciclovax Portugal
Aciclovir Argentina, Australia, Belgium, Chile, Colombia, Ecuador, Egypt, Finland, France, Germany, Great Britain, Iran, Ireland, Italy, Luxembourg, Malaysia, New Zealand, Norway, Peru, Poland, Spain, Sweden, Tunisia
Acivir India
Acix Poland
Acyclovir Canada, Denmark, Finland, Malaysia, Sweden, Switzerland, United Arab Emirates, United States of America
Acyrax Finland
Antivirax Brazil
Axovir India
Cevirin India
Cicloferon Mexico
Cicloviral Morocco, Portugal
Cusiviral Spain
Cycloviran Italy
Eurovir Chile
Geavir Denmark, Finland, Sweden
Herpesin Hungary, Poland
Herzovir India, Malaysia
Isavir Colombia, Mexico
Klorvireks Malaysia, Turkey
Lafevir Argentina
Lovir India
Lovrak Saudi Arabia, United Arab Emirates
Maynar Spain
Medovir Malaysia
Mevirox Tunisia
Nisivir India
Nycovir Austria
Olcicavar Mexico
Ovir India
Sanavir Italy
Supraviran Egypt, Germany, United Arab Emirates
Trixviral Argentina
Vacrax India, Malaysia
Vircidal Colombia
Virex Colombia
Virherpes Spain
Virmen Spain
Virolex Hungary, Poland, Romania
Virulax Venezuela
Xiclovir Argentina
Xorox Austria
Zovir Iceland
Zovirax Australia, Austria, Belgium, Brazil, Chile, Colombia, Egypt, Finland, France, Germany, Great Britain, Greece, India, Iran, Ireland, Italy, Luxembourg, Malaysia, Mexico, Morocco, Netherlands, Poland, Saudi Arabia, Spain, Sweden, Switzerland, Tunisia, Turkey, United States of America
Zoylex India, Peru
Stability in solutions   Injection   Stability in solutions : Aciclovir sodium     
Container Solvent Concentration Temperature Storage Length of time References
Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 & 7 & 10 mg/ml 4°C Protect from light
35 Day
822
Level of evidence A+

Polyvinyl chloride NaCl 0,9% or Glucose 5% 5 mg/ml 25°C Not specified
37 Day
68
Level of evidence C

Polyvinyl chloride NaCl 0,9% or Glucose 5% 5 mg/ml 5°C Protect from light
37 Day
68
Level of evidence C

Polyvinyl chloride Sodium chloride 0,9% 1 & 7 & 10 mg/ml 23°C Protect from light
7 Day
822
Level of evidence A+

Polyvinyl chloride Glucose 5% 1 & 7 & 10 mg/ml 23°C Protect from light
21 Day
822
Level of evidence A+

Polyethylene NaCl 0,9% or Glucose 5% 5 mg/ml 22°C Protect from light
24 Hour
1067
Level of evidence C

Polyethylene NaCl 0,9% or Glucose 5% 5 mg/ml 4°C Protect from light
24 Hour
1067
Level of evidence C

Polyolefine Sodium chloride 0,9% 5 mg/ml -20°C Protect from light
90 Day
3001
Level of evidence D

Polyolefine Sodium chloride 0,9% 5 mg/ml 2-8°C Not specified
21 Day
3001
Level of evidence D

Polypropylen Syringe Sodium chloride 0,9% 10 mg/ml 25°C Not specified
30 Day
1717
Level of evidence C

Polyisoprene elastomer Sodium chloride 0,9% 1 & 10 mg/ml 25°C Not specified
4 Day
604
Manufacturer's stability data


  Mentions Légales